Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,628
datasets available to search
ShareScore release 0.9.0
Dataset results
1,628 results for “type safety”
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
ClinicalTrials.gov study NCT02098395. IPD Sharing: Not stated. Countries: 13. Publications: 4.
Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 Diabetes
ClinicalTrials.gov study NCT01606007. IPD Sharing: Not stated. Countries: 8. Publications: 3.
Effects of Exenatide Long-Acting Release on Glucose Control and Safety in Subjects With Type 2 Diabetes Mellitus(DURATION - 1)
ClinicalTrials.gov study NCT00308139. IPD Sharing: Not stated. Countries: 2. Publications: 10.
Safety, Pharmacokinetics and Pharmacodynamics of TA-7284 in Type 2 Diabetic Patients
ClinicalTrials.gov study NCT00707954. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Type 1 Diabetes Subjects
ClinicalTrials.gov study NCT03378635. IPD Sharing: NO. Countries: 4. Publications: 1.
Safety Follow-up on Children and Adolescents With Type 1 Diabetes Treated With Insulin Detemir. An Extension to Trial NN304-1689
ClinicalTrials.gov study NCT00623194. IPD Sharing: Not stated. Countries: 11. Publications: 1.
Phase IIb Safety and Efficacy Study of Different Oral Doses of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT01807221. IPD Sharing: Not stated. Countries: 25. Publications: 4.
Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes
ClinicalTrials.gov study NCT01885208. IPD Sharing: Not stated. Countries: 13. Publications: 18.
Efficacy and Safety of Alogliptin Combined With Pioglitazone in Treating Subjects With Type 2 Diabetes Mellitus.
ClinicalTrials.gov study NCT00328627. IPD Sharing: Not stated. Countries: 19. Publications: 1.
A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes
ClinicalTrials.gov study NCT03495102. IPD Sharing: YES. Countries: 16. Publications: 3.
Efficacy and Safety Study of MP-513 in Combination With Sulfonylurea in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00974090. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety Study of DWP-450 (Botulinum Purified Neurotoxin, Type A) Injection to Treat Glabellar Lines
ClinicalTrials.gov study NCT02184988. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
ClinicalTrials.gov study NCT02025907. IPD Sharing: Not stated. Countries: 5. Publications: 1.
12 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Patients With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT01370005. IPD Sharing: YES. Countries: 12. Publications: 4.
Safety and Efficacy of LX4211 With Metformin in Type 2 Diabetes Patients With Inadequate Glycemic Control on Metformin
ClinicalTrials.gov study NCT01376557. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Tr
ClinicalTrials.gov study NCT00309244. IPD Sharing: Not stated. Countries: 10. Publications: 2.
Safety and Efficacy of CLBS03 in Adolescents With Recent Onset Type 1 Diabetes (The Sanford Project T-Rex Study)
ClinicalTrials.gov study NCT02691247. IPD Sharing: NO. Countries: 1. Publications: 1.
Evaluation of the Safety and Efficacy of Insulin Glargine 300 U/ml (Gla-300) in Insulin-naïve Patients With Type 2 Diabetes Mellitus Uncontrolled on Oral Antihyperglycemic Drugs
ClinicalTrials.gov study NCT04980027. IPD Sharing: YES. Countries: 1. Publications: 1.
Safety and Efficacy of Two Types of Botulinum Toxin Type A For the Treatment of Glabellar Lines
ClinicalTrials.gov study NCT01271452. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Multiple-ascending-dose Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of MEDI0382 in Overweight and Obese Participants With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT02548585. IPD Sharing: Not stated. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.